Thought Leadership
At NDA our experts stay abreast with the evolving environment and the new regulatory requirements that it gives rise to. One of the results of these activities is a stream of articles, commentaries and white papers that we publish for the benefit of our clients and followers. It captures the state of the art of our industry today.
We call it Thought Leadership.
Articles and White Papers
Service:
Scientific:
Sort by:
All services
Development Strategy
Medical Devices
Pharmacovigilance
NDA Advisory Board
Strategic Communications
Regulatory
Quality & Compliance
All expertise
Oncology
Vaccine
Immunogenicity
HTA
In-Vitro Diagnostics
Non-Clinical
Cell and Gene Therapy
Biostatistics
Cardiology
ATMP
Rare Disease
Market Access
CMC
Clinical
Paediatric
Acceleration Strategies
Medical Devices
Quality
Patient Safety
29-05-2023
Joint Clinical Assessments – Mandatory EU-Level Evaluations for Health Technology Assessment
This white paper authored by NDA Advisory Board member Sigrid Klaar, provides a comprehensive overview of the JCA procedure for medicines.
17-05-2023
Why is a potency assay important for cell and gene therapy products?
Paula Salmikangas, Björn Carlsson, Christophe Klumb and Tatiana Reimer together with Prof. Steffen Thirstrup published an article in Frontiers in Medicine, Regulatory Science.
17-05-2023
Releasing the potential of patient and public perspective
This article, co-authored by Dr Lisa Campbell, Medical Advisor at NDA highlights a number of patient and public involvement and engagement (PPIE) initiatives by regulatory agencies and regulatory science centres.
17-05-2023
Regulatory framework for real-world data progresses
In the November / December issue of MedNous, Dr Chantal van Gils, Director of Epidemiology and Real-World Evidence, provides some insights into the regulatory framework for real-world data progress
09-05-2023
Project Optimus – A Reform in the Dose Optimization and Selection in Oncology Drug Development
In this white paper, Dr Laurie Smaldone Alsup, Chief Medical & Scientific Officer at NDA, explores the goals of Project Optimus and how it can impact time to approval.
13-04-2023
Translational Research
This article explains the crucial steps you need to take to translate basic science into clinical practice.